Utilidad de la deoxiglucosa marcada con flúor-18 (FDG) en el manejo de los linfomas

Positron emission tomography (PET) with fluorine-18 labeled deoxyglucose (FDG) is useful in the management of lymphomas. In this review, some general concepts of this metabolic test are defined. It has an excellent diagnostic yield in Hodgkin disease as well as in most non Hodgkin lymphomas. Staging...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Massardo V,Teresa, Canessa G,José, Jofré M,M Josefina, González E,Patricio, Humeres A,Pamela, Sierralta G,Paulina
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Médica de Santiago 2006
Materias:	Fluorine-18-fluorodeoxyglucose Hodgkin disease Lymphoma, non-Hodgkin Positron-emission tomography
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872006000700016
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0034-98872006000700016
record_format	dspace
spelling	oai:scielo:S0034-988720060007000162006-08-29Utilidad de la deoxiglucosa marcada con flúor-18 (FDG) en el manejo de los linfomasMassardo V,TeresaCanessa G,JoséJofré M,M JosefinaGonzález E,PatricioHumeres A,PamelaSierralta G,Paulina Fluorine-18-fluorodeoxyglucose Hodgkin disease Lymphoma, non-Hodgkin Positron-emission tomography Positron emission tomography (PET) with fluorine-18 labeled deoxyglucose (FDG) is useful in the management of lymphomas. In this review, some general concepts of this metabolic test are defined. It has an excellent diagnostic yield in Hodgkin disease as well as in most non Hodgkin lymphomas. Staging, restaging residual mass evaluation and the control of therapy are the main indications for FDG-PET. Images with FDG have a high diagnostic and prognostic value, that is superior to anatomical images and conventional staging techniques. They are also helpful for the assessment of tumor activity in abnormal lymph nodes or large masses that have been treated and reduce their size slowly or show an incomplete resolution. Currently, the resolution of dedicated PET equipments is 6 mm and bigger lesions can easily be detected. The main differences and advantages of FDG versus gallium-67 in lymphoma are also discussed, as well as the initial local experience with the technique in lymphoma patientsinfo:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.134 n.7 20062006-07-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872006000700016es10.4067/S0034-98872006000700016
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	Fluorine-18-fluorodeoxyglucose Hodgkin disease Lymphoma, non-Hodgkin Positron-emission tomography
spellingShingle	Fluorine-18-fluorodeoxyglucose Hodgkin disease Lymphoma, non-Hodgkin Positron-emission tomography Massardo V,Teresa Canessa G,José Jofré M,M Josefina González E,Patricio Humeres A,Pamela Sierralta G,Paulina Utilidad de la deoxiglucosa marcada con flúor-18 (FDG) en el manejo de los linfomas
description	Positron emission tomography (PET) with fluorine-18 labeled deoxyglucose (FDG) is useful in the management of lymphomas. In this review, some general concepts of this metabolic test are defined. It has an excellent diagnostic yield in Hodgkin disease as well as in most non Hodgkin lymphomas. Staging, restaging residual mass evaluation and the control of therapy are the main indications for FDG-PET. Images with FDG have a high diagnostic and prognostic value, that is superior to anatomical images and conventional staging techniques. They are also helpful for the assessment of tumor activity in abnormal lymph nodes or large masses that have been treated and reduce their size slowly or show an incomplete resolution. Currently, the resolution of dedicated PET equipments is 6 mm and bigger lesions can easily be detected. The main differences and advantages of FDG versus gallium-67 in lymphoma are also discussed, as well as the initial local experience with the technique in lymphoma patients
author	Massardo V,Teresa Canessa G,José Jofré M,M Josefina González E,Patricio Humeres A,Pamela Sierralta G,Paulina
author_facet	Massardo V,Teresa Canessa G,José Jofré M,M Josefina González E,Patricio Humeres A,Pamela Sierralta G,Paulina
author_sort	Massardo V,Teresa
title	Utilidad de la deoxiglucosa marcada con flúor-18 (FDG) en el manejo de los linfomas
title_short	Utilidad de la deoxiglucosa marcada con flúor-18 (FDG) en el manejo de los linfomas
title_full	Utilidad de la deoxiglucosa marcada con flúor-18 (FDG) en el manejo de los linfomas
title_fullStr	Utilidad de la deoxiglucosa marcada con flúor-18 (FDG) en el manejo de los linfomas
title_full_unstemmed	Utilidad de la deoxiglucosa marcada con flúor-18 (FDG) en el manejo de los linfomas
title_sort	utilidad de la deoxiglucosa marcada con flúor-18 (fdg) en el manejo de los linfomas
publisher	Sociedad Médica de Santiago
publishDate	2006
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872006000700016
work_keys_str_mv	AT massardovteresa utilidaddeladeoxiglucosamarcadaconfluor18fdgenelmanejodeloslinfomas AT canessagjose utilidaddeladeoxiglucosamarcadaconfluor18fdgenelmanejodeloslinfomas AT jofremmjosefina utilidaddeladeoxiglucosamarcadaconfluor18fdgenelmanejodeloslinfomas AT gonzalezepatricio utilidaddeladeoxiglucosamarcadaconfluor18fdgenelmanejodeloslinfomas AT humeresapamela utilidaddeladeoxiglucosamarcadaconfluor18fdgenelmanejodeloslinfomas AT sierraltagpaulina utilidaddeladeoxiglucosamarcadaconfluor18fdgenelmanejodeloslinfomas
_version_	1718436272354099200

Utilidad de la deoxiglucosa marcada con flúor-18 (FDG) en el manejo de los linfomas

Ejemplares similares